West Pharmaceutical Services just sent investors $0.22 per share on February 4, 2026, marking the company's latest quarterly dividend payment.
Cibc World Market Inc. grew its position in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 300.0% during the undefined quarter, according to its most recent Form 13F filing with the Secur
Caprock Group LLC purchased a new position in shares of West Pharmaceutical Services, Inc. (NYSE: WST) during the undefined quarter, according to the company in its most recent filing with the SEC. Th
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either The Cooper Companies (COO) or West Pharmaceutical Services (WST). But which of these two companies is
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript
West Pharmaceutical beats Q4 EPS and revenue estimates as proprietary products drive growth, while shares jump nearly 3.6% premarket on upbeat 2026 outlook.
Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare wit
West Pharmaceutical Services (WST) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.83 per share. This compares to earnings of $1.82 per share a year ago
West Pharmaceutical forecast annual profit above Wall Street estimates on Thursday, after beating fourth-quarter expectations on strong demand for its proprietary products, which include syringes and
– Strong 4Q results, driven by double-digit organic revenue growth in HVP Components – – Introduces Fiscal 2026 Financial Guidance – EXTON, Pa., Feb. 12, 2026 /PRNewswire/ -- West Pharmaceutic
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for West Pharmaceutical (WST), delve into some of its key metrics to gain a deeper insight into the company's potential performance
Rockland Trust Co. boosted its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 6.5% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The in
West Pharmaceutical heads into Q4 with HVP demand likely lifting margins, but tariff risk looms as revenue and EPS targets come into focus.
ProShare Advisors LLC lessened its position in West Pharmaceutical Services, Inc. (NYSE: WST) by 17.0% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institut
West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE